miRNAs may affect 5-FU resistance or sensitivity by regulating the main signaling pathways involved in CRC, including the PI3K/AKT, Wnt/β-catenin, and Notch signaling pathways [53]. This evidence concerns the gene AKT1 and colorectal carcinoma.